Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3473419018 | Vesicular monoamine transporter 2 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3473421011 | VMAT2 inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
3646404014 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3646405010 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Vesicular monoamine transporter 2 inhibitor | Is a | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | false | Inferred relationship | Some | ||
Vesicular monoamine transporter 2 inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Vesicular monoamine transporter 2 inhibitor (disposition) | true | Inferred relationship | Some | ||
Vesicular monoamine transporter 2 inhibitor | Is a | Substance categorized by disposition | false | Inferred relationship | Some | ||
Vesicular monoamine transporter 2 inhibitor | Is a | Substance with cellular transport inhibitor mechanism of action (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Deutetrabenazine | Is a | True | Vesicular monoamine transporter 2 inhibitor | Inferred relationship | Some | |
Valbenazine | Is a | True | Vesicular monoamine transporter 2 inhibitor | Inferred relationship | Some | |
Product containing vesicular monoamine transporter 2 inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Vesicular monoamine transporter 2 inhibitor | Inferred relationship | Some | 1 |
Tetrabenazine | Is a | True | Vesicular monoamine transporter 2 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets